000 | 01940 a2200517 4500 | ||
---|---|---|---|
005 | 20250517162410.0 | ||
264 | 0 | _c20190529 | |
008 | 201905s 0 0 eng d | ||
022 | _a1558-3597 | ||
024 | 7 |
_a10.1016/j.jacc.2017.04.007 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSable, Craig A | |
245 | 0 | 0 |
_a2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil. _h[electronic resource] |
260 |
_bJournal of the American College of Cardiology _c07 2017 |
||
300 |
_a495-503 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aCardiology _xmethods |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild Advocacy |
650 | 0 | 4 |
_aChild Health _xlegislation & jurisprudence |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aDrug Development _xmethods |
650 | 0 | 4 |
_aDrug and Narcotic Control _xorganization & administration |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension, Pulmonary _xdrug therapy |
650 | 0 | 4 | _aMortality |
650 | 0 | 4 |
_aOff-Label Use _xlegislation & jurisprudence |
650 | 0 | 4 |
_aOutcome Assessment, Health Care _xethics |
650 | 0 | 4 |
_aPediatrics _xmethods |
650 | 0 | 4 |
_aRandomized Controlled Trials as Topic _xethics |
650 | 0 | 4 |
_aSildenafil Citrate _xadministration & dosage |
650 | 0 | 4 |
_aVasodilator Agents _xadministration & dosage |
700 | 1 | _aIvy, D Dunbar | |
700 | 1 | _aBeekman, Robert H | |
700 | 1 | _aClayton-Jeter, Helene D | |
700 | 1 | _aJenkins, Kathy J | |
700 | 1 | _aMahle, William T | |
700 | 1 | _aMorrow, William R | |
700 | 1 | _aMurphy, Mary Dianne | |
700 | 1 | _aNelson, Robert M | |
700 | 1 | _aRosenthal, Geoffrey L | |
700 | 1 | _aStockbridge, Norman | |
700 | 1 | _aWessel, David L | |
773 | 0 |
_tJournal of the American College of Cardiology _gvol. 70 _gno. 4 _gp. 495-503 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jacc.2017.04.007 _zAvailable from publisher's website |
999 |
_c27330825 _d27330825 |